Company Overview and News

 
Australia's Capilano Honey benefits from Comvita JV

2017-08-07 nzherald.co.nz
Australian honey maker Capilano Honey's joint venture with Comvita has had an immediate, if unrealised, benefit for the Queensland-based company's bottom line.

 
Global Honey Food Market 2017-2021

2017-04-04 prnewswire
LONDON, April 4, 2017 /PRNewswire/ -- About Honey Food Honey is a sweet food produced by bees foraging nectar from flowers. Honey bees convert nectar to honey through regurgitation and evaporation. The bees store the honey as a primary food source in wax honeycombs inside beehives. The beekeepers extract the honey by removing the honey comb and then by crushing it or using a honey extractor. Honey bees form an important part of the food chain as they aid in pollination, which is required to support the food chain.

 
Australian honey is as at least as potent as New Zealand manuka, study finds

2016-12-28 smh.com.au
Australian manuka-style honey is as least as medically powerful as New Zealand manuka honey, a study has found.

 
Australian market set to open up

2016-11-17 ntnews.com.au
THE Australian market looks set to open slightly higher following positive sessions on most major international markets and with Wall Street’s S&P 500 lifting close to a record high.

 
Australian market set to open up

2016-11-17 perthnow.com.au
THE Australian market looks set to open slightly higher following positive sessions on most major international markets and with Wall Street’s S&P 500 lifting close to a record high.

 
Woolworths' used 'slapdash and haphazard' methods to fill profit gap, court told

2016-10-31 theage.com.au
Woolworths' attempts to extract payments from suppliers to fill a $50 million hole in its profits were "slapdash, haphazard, unbusiness-like and unreasonable", a Sydney court heard on Monday.

 
Woolworths' used 'slapdash and haphazard' methods to fill profit gap, court told

2016-10-31 smh.com.au
Woolworths' attempts to extract payments from suppliers to fill a $50 million hole in its profits were "slapdash, haphazard, unbusiness-like and unreasonable", a Sydney court heard on Monday.

 
Australia and New Zealand battling over manuka, the champagne of honeys

2016-08-25 theage.com.au
There's a fight Down Under over manuka honey, the so-called superfood famed for its antibacterial qualities. On one side, New Zealand beehive owners say they should have exclusive rights to the manuka name. On the other, Australian producers say the manuka tree that gives the sticky stuff its name is an Aussie native and their honey is just as super as its Kiwi cousin.

 
Australia and New Zealand battling over manuka, the champagne of honeys

2016-08-25 smh.com.au
There's a fight Down Under over manuka honey, the so-called superfood famed for its antibacterial qualities. On one side, New Zealand beehive owners say they should have exclusive rights to the manuka name. On the other, Australian producers say the manuka tree that gives the sticky stuff its name is an Aussie native and their honey is just as super as its Kiwi cousin.

 
There's a Battle to Trademark Manuka, the Champagne of Honeys - Bloomberg

2016-08-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Four China-themed stocks that are still affordable, according to UBS

2016-06-07 smh.com.au
It's not too late to buy into the year's most hyped investment theme, stocks that are geared to China's growing consumer base, UBS says.  

 
Capilano Honey Ltd gets ready to raise

2016-05-18 proactiveinvestors.com.au
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.

 
Capilano Honey delivers investors a sweet treat

2016-02-08 theage.com.au
Soaring sales to Asia have helped Australia's biggest honey packer defy supply cost rises to deliver a 53 per cent surge in net profit.

 
Capilano Honey delivers investors a sweet treat

2016-02-08 smh.com.au
Soaring sales to Asia have helped Australia's biggest honey packer defy supply cost rises to deliver a 53 per cent surge in net profit.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...